Mr. Sieczkarek was appointed Chairman of the Board of NovaBay in April 2015. He served as past CEO and Chairman of the Board of Solta Medical, Inc. and served as a director for seven years until it was acquired by Valeant Pharmaceuticals International, Inc. in January 2014. Mr. Sieczkarek has more than 18 years of leadership experience in the medical device industry and served as President and Chief Executive Officer of Conceptus, Inc. from 2003 to 2011. Previously, Mr. Sieczkarek was Senior Vice President and President of The Americas Region, responsible for the commercial operation of all Bausch & Lomb businesses in the United States, Canada and Latin America. Mark joined Bausch & Lomb in 1995 as Vice President and Controller in the Personal Products division and also served as a Vice President in Corporate Business Development. Previously, Mark held an executive level position with KOS Pharmaceuticals, several Bristol Myers-Squibb subsidiaries and Sanofi Diagnostics Pasteur. Mr. Sieczkarek received a MBA degree in Finance from Canisus College in Buffalo, NY, and a B.S. degree in Accounting from the State University of New York at Buffalo.

 Pharmaceuticals, Business